Tumor-associated antigens (TAAs) with potential for ADC targeting in cervical cancer include TF, human epidermal growth factor receptor 2 (HER2), trophoblast cell surface antigen 2 (Trop-2), mesothelin, and Nectin cell adhesion molecule 4 (Nectin-4) (Table 2). The gene discussed is ERBB2; the disease is cervical carcinoma.